Lau, G.K.
13276  Ergebnisse:
Personensuche X
?
 
?
2

Central nervous system inflammatory demyelinating disorders..:

Chan, K.H. ; Lee, R. ; Lee, J.C.Y....
Journal of Neuroimmunology.  262 (2013)  1-2 - p. 100-105 , 2013
 
?
3

Management of Chronic Hepatitis B e Antigen-Negative Diseas..:

Lau, G. K. K. ; Wang, F.-S.
Journal of Infectious Diseases.  205 (2011)  1 - p. 7-9 , 2011
 
?
4

Intracellular levels of hepatitis B virus DNA and pregenomi..:

Lu, L. ; Zhang, H.‐Y. ; Yueng, Y.‐H....
Journal of Viral Hepatitis.  16 (2009)  2 - p. 104-112 , 2009
 
?
 
?
12

OL-015 A pharmacogenomics approach to predict the efficacy ..:

Hwang, Y.C. ; Lau, G.K.K. ; Kao, J.H....
International Journal of Infectious Diseases.  12 (2008)  - p. S39-S40 , 2008
 
?
13

Clinical trial: a phase II, randomized study evaluating the..:

LIM, S. G. ; LEUNG, N. ; HANN, H. W. L....
Alimentary Pharmacology & Therapeutics.  27 (2008)  12 - p. 1282-1292 , 2008
 
?
14

48 weeks pegylated interferon alpha‐2a is superior to 24 we..:

HUI, C.‐K. ; LAI, L. S. W. ; LAM, P....
Alimentary Pharmacology & Therapeutics.  23 (2006)  8 - p. 1171-1178 , 2006
 
1-15